TrademarkOpen
Search / United States / 97288153

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

ATTRUBY

Registered
Used for: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic…
Show more

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 3 Mar 2022
    Application filed
    Nwap
  2. 11 Dec 2022
    Assigned to an examining attorney
    Dock
  3. 14 Dec 2022
    Approved for publication
    Cnsa
  4. 17 Jan 2023
    Published for opposition
    Pubo
  5. 14 Mar 2023
    Notice of allowance issued — statement of use required
    Noam
  6. 11 Aug 2023
    Statement-of-use extension 1 granted
    Ex1g
  7. 8 Feb 2024
    Statement-of-use extension 2 granted
    Ex2g
  8. 28 Jul 2024
    Statement-of-use extension 3 granted
    Ex3g
  9. 5 Feb 2025
    Statement of use filed
    Eisu
  10. 9 May 2025
    Statement of use accepted
    Cnpr
  11. 3 Jun 2025
    Registered on the Principal Register
    R.pr
All 34 events
2025-06-03R.pr
2025-06-03Nrcc
2025-05-09Cnpr
2025-05-09Suna
2025-04-16Aitu
2025-04-16Supc
2025-02-06Ex4g
2025-02-06Exra
2025-02-05Eext
2025-02-05Ext4
2025-02-05Eisu
2025-02-05Iuaf
2024-07-28Eext
2024-07-28Ext3
2024-07-28Ex3g
2024-02-09Exra
2024-02-08Eext
2024-02-08Ext2
2024-02-08Ex2g
2023-08-15Exra
2023-08-11Eext
2023-08-11Ext1
2023-08-11Ex1g
2023-03-14Noam
2023-01-17Pubo
2023-01-17Npub
2022-12-28Nonp
2022-12-14Cnsa
2022-12-13Coar
2022-12-13Tcca
2022-12-13Chan
2022-12-11Dock
2022-03-03Nwap
2022-03-03Nwos

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

First use anywhere 22 Nov 2024 · First use in commerce 22 Nov 2024

Source & freshness

Source: the official United States trademark register. This record was last updated on 3 Jun 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.